• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构变异对靶向前列腺癌的抗 PSMA scFv 和免疫毒素生物活性的影响。

Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.

机构信息

Department of Urology, University Hospital Freiburg, Breisacher Strasse 117, 79106 Freiburg, Germany.

出版信息

Anticancer Res. 2010 Sep;30(9):3373-9.

PMID:20944111
Abstract

BACKGROUND

In this study, different variants of the anti-PSMA single-chain antibody fragment (scFv) D7 were cloned, varying in linker type, position of hexahistidine tags and VH-VL orientation. From these scFv, Pseudomonas exotoxin A-based immunotoxins were constructed and their biological activities against prostate cancer cells were compared.

MATERIALS AND METHODS

Binding of the constructs to PSMA-expressing prostate cancer cells was determined by flow cytometry. ADP-ribosyltransferase activity was analysed and cytotoxicity was measured with WST-1 assays.

RESULTS

Different linker types did not influence the characteristics of the scFv or immunotoxins. The addition of an N-terminal hexahistidine-tag, however, resulted in decreased expression, binding and cytotoxicity. scFv in VH-VL orientation showed the highest expression and binding, whereas immunotoxins in VL-VH orientation exhibited the best binding and cytotoxicity.

CONCLUSION

The present study showed how structure influences the characteristics of scFv and immunotoxins. It is therefore suggested that for each individual construct the optimal structure has to be determined separately.

摘要

背景

在这项研究中,克隆了不同变体的抗 PSMA 单链抗体片段 (scFv) D7,其连接类型、六组氨酸标签的位置和 VH-VL 方向不同。从这些 scFv 中构建了基于假单胞菌外毒素 A 的免疫毒素,并比较了它们对前列腺癌细胞的生物学活性。

材料和方法

通过流式细胞术测定构建物与表达 PSMA 的前列腺癌细胞的结合。分析 ADP-核糖基转移酶活性,并用 WST-1 测定法测量细胞毒性。

结果

不同的连接类型不会影响 scFv 或免疫毒素的特性。然而,添加 N 端六组氨酸标签会导致表达、结合和细胞毒性降低。以 VH-VL 方向排列的 scFv 表现出最高的表达和结合,而以 VL-VH 方向排列的免疫毒素则表现出最佳的结合和细胞毒性。

结论

本研究表明结构如何影响 scFv 和免疫毒素的特性。因此,建议对于每个单独的构建体,都必须单独确定最佳结构。

相似文献

1
Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.结构变异对靶向前列腺癌的抗 PSMA scFv 和免疫毒素生物活性的影响。
Anticancer Res. 2010 Sep;30(9):3373-9.
2
Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer.抗前列腺特异性膜抗原单链免疫毒素对前列腺癌的临床前评价。
J Immunother. 2010 Apr;33(3):262-71. doi: 10.1097/CJI.0b013e3181c5495c.
3
Evaluation of Humanized/De-immunized Anti-PSMA Immunotoxins for the Treatment of Prostate Cancer.用于治疗前列腺癌的人源化/去免疫抗前列腺特异性膜抗原免疫毒素的评估
Anticancer Res. 2018 Jan;38(1):61-69. doi: 10.21873/anticanres.12192.
4
Combination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer.PI3K抑制剂ZSTK474与靶向PSMA的免疫毒素联合使用可加速前列腺癌的细胞凋亡和消退。
Neoplasia. 2013 Oct;15(10):1172-83. doi: 10.1593/neo.13986.
5
Higher cytotoxicity of divalent antibody-toxins than monovalent antibody-toxins.二价抗体毒素比单价抗体毒素具有更高的细胞毒性。
Biochem Biophys Res Commun. 2009 Apr 24;382(1):15-20. doi: 10.1016/j.bbrc.2009.02.091. Epub 2009 Feb 24.
6
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.用于前列腺癌诊断和免疫治疗的新型靶向前列腺干细胞抗原(PSCA)的单链抗体片段(scFv)融合蛋白
J Cancer Res Clin Oncol. 2017 Oct;143(10):2025-2038. doi: 10.1007/s00432-017-2472-9. Epub 2017 Jun 30.
7
A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.一种毒素的驯化指南——用绿脓杆菌外毒素 A 构建的重组免疫毒素用于癌症治疗。
FEBS J. 2011 Dec;278(23):4683-700. doi: 10.1111/j.1742-4658.2011.08182.x. Epub 2011 Jun 2.
8
In vivo efficacy of the recombinant anti-CD64 immunotoxin H22(scFv)-ETA' in a human acute myeloid leukemia xenograft tumor model.重组抗 CD64 免疫毒素 H22(scFv)-ETA' 在人急性髓系白血病异种移植肿瘤模型中的体内疗效。
Int J Cancer. 2011 Sep 1;129(5):1277-82. doi: 10.1002/ijc.25766. Epub 2011 Feb 26.
9
Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxins.一组抗CD3单链抗体片段免疫毒素中相对结合亲和力对疗效的影响。
Mol Immunol. 2001 Sep;38(5):397-408. doi: 10.1016/s0161-5890(01)00070-0.
10
Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.构建、表达并鉴定包含人源抗 c-Met 单链抗体和 PE38KDEL 的抗肿瘤免疫毒素。
Immunol Lett. 2013 Jan;149(1-2):30-40. doi: 10.1016/j.imlet.2012.09.006. Epub 2012 Sep 29.

引用本文的文献

1
Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.中和抗体足迹的结构和病毒学鉴定为抗SARS-CoV-2变体治疗性抗体的设计提供了见解。
Commun Biol. 2025 Mar 22;8(1):483. doi: 10.1038/s42003-025-07827-0.
2
Thermostability and binding properties of single-chained Fv fragments derived from therapeutic antibodies.治疗性抗体单链 Fv 片段的热稳定性和结合特性。
Protein Sci. 2024 Jul;33(7):e5084. doi: 10.1002/pro.5084.
3
Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein.
鉴定针对狂犬病毒糖蛋白的中和抗体的单链 Fv 片段。
Viruses. 2021 Nov 19;13(11):2311. doi: 10.3390/v13112311.
4
Targeted Toxins for the Treatment of Prostate Cancer.用于治疗前列腺癌的靶向毒素
Biomedicines. 2021 Aug 9;9(8):986. doi: 10.3390/biomedicines9080986.
5
Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.胶质母细胞瘤的重组免疫毒素疗法:巧妙设计、关键发现及特殊挑战
Biomed Res Int. 2017;2017:7929286. doi: 10.1155/2017/7929286. Epub 2017 Jun 29.
6
A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.一种新型抗p21Ras单链抗体,可特异性与人肿瘤细胞系和原发性肿瘤组织发生反应。
BMC Cancer. 2016 Feb 20;16:131. doi: 10.1186/s12885-016-2168-6.
7
A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression.一种对表达EGFR和EGFRvIII的肿瘤具有高效力的二价重组免疫毒素。
Cancer Biol Ther. 2015;16(12):1764-74. doi: 10.1080/15384047.2015.1095403.
8
Cloning murine antibody V-genes with non-degenerate primers and conversion to a recombinant antibody format.使用非简并引物克隆鼠源抗体V基因并转化为重组抗体形式。
Monoclon Antib Immunodiagn Immunother. 2014 Dec;33(6):369-77. doi: 10.1089/mab.2014.0044.
9
Recombinant Immunotoxin Therapy of Solid Tumors: Challenges and Strategies.实体瘤的重组免疫毒素疗法:挑战与策略
J Basic Clin Med. 2013;2(2):1-6.
10
The efficacy of NP11-4-derived immunotoxin scFv-artesunate in reducing hepatic fibrosis induced by Schistosoma japonicum in mice.NP11-4衍生免疫毒素单链抗体片段-青蒿琥酯在减轻日本血吸虫诱导的小鼠肝纤维化中的疗效。
J Biomed Res. 2011 Mar;25(2):148-54. doi: 10.1016/S1674-8301(11)60019-5.